Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Abstract

Tamoxifen decreases the incidence of invasive and noninvasive breast cancer. Despite side effects resulting from administration of tamoxifen, its use as a breast cancer preventive agent is appropriate in many women at increased risk for the disease.

Keywords

TamoxifenMedicineBreast cancerLobular carcinomaCumulative incidenceOncologyGynecologyInternal medicineCancerIncidence (geometry)ObstetricsDuctal carcinomaCohort

Affiliated Institutions

Related Publications

Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value.

P J van Diest , Rob Michalides , L Jannink +5 more

Cyclin D1 overexpression, detected by standard immunohistochemistry, was correlated with other prognostic variables and its prognostic value was evaluated in a group of 148 inva...

1997 PubMed 208 citations

Randomized Trial of Two Versus Five Years of Adjuvant Tamoxifen for Postmenopausal Early Stage Breast Cancer

Five years of adjuvant tamoxifen is more beneficial than 2 years in the treatment of postmenopausal women with estrogen receptor-positive, early stage, invasive breast cancer.

1996 JNCI Journal of the National Cancer I... 263 citations

Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer. An Overview of 61 Randomised Trials Among 28,896 Women

R Peto

We sought information worldwide on mortality according to assigned treatment in all randomised trials that began before 1985 of adjuvant tamoxifen or cytotoxic therapy for early...

1989 Hormone Research 40 citations

Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.

Bernard Fisher , Carol Redmond , S Legault-Poisson +7 more

The National Surgical Adjuvant Breast and Bowel Project (NSABP) conducted a randomized clinical trial to determine whether tamoxifen (TAM) plus chemotherapy is more effective th...

1990 Journal of Clinical Oncology 294 citations

Breast cancer estrogen and progesterone receptor values: their distribution, degree of concordance, and relation to number of positive axillary nodes.

Bernard Fisher , D. Lawrence Wickerham , A Brown +1 more

Increasing evidence indicates the importance of ascertaining the quantitative estrogen receptor (ER) and progesterone receptor (PR) content (in femtomoles per milligram cytosol ...

1983 Journal of Clinical Oncology 40 citations

Publication Info

Year: 1998
Type: article
Volume: 90
Issue: 18
Pages: 1371-1388
Citations: 5480
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

5480

OpenAlex

Cite This

APA Style

                            
                                
                                    Bernard Fisher, 
                                
                                    Joseph P. Costantino, 
                                
                                    D. Lawrence Wickerham
                                
                                et al.
                            
                            (1998). 
                            Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. 
                            JNCI Journal of the National Cancer Institute
                            , 90
                            (18)
                            , 1371-1388.
                            https://doi.org/10.1093/jnci/90.18.1371
                        

Identifiers

DOI: 10.1093/jnci/90.18.1371